Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Anna Russolillo, Roberta Lupoli, Raffaele Scarpa

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objectives: To evaluate prospectively the effect of weight loss on the achievement of minimal disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting treatment with tumour necrosis factor α (TNFα) blockers. Methods: Among subjects with PsA starting treatment with TNFα blockers, 138 overweight/obese patients received a concomitant dietary intervention (69 a hypocaloric diet (HD) and 69 a free-managed diet (FD)). Changes in metabolic variables were measured and a complete clinical rheumatological evaluation was made in all patients at baseline and after a 6-month follow-up to define the achievement of MDA. Results: 126 subjects completed the study. MDA was more often achieved by HD than by FD subjects (HR=1.85, 95% CI 1.019 to 3.345, p=0.043). A diet was successful (≥5% weight loss) in 74 (58.7%) patients. Regardless of the type of diet, after 6 months of treatment with TNFα blockers, ≥5% of weight loss was a predictor of the achievement of MDA (OR=4.20, 95% CI 1.82 to 9.66, p10%), MDA was achieved by 23.1%, 44.8% and 59.5%, respectively. A higher rate of MDA achievement was found in subjects with 5-10% (OR=3.75, 95% CI 1.36 to 10.36, p=0.011) and in those with >10% (OR=6.67, 95% CI 2.41 to 18.41, p

Original languageEnglish
Pages (from-to)1157-1162
Number of pages6
JournalAnnals of the Rheumatic Diseases
Volume73
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Psoriatic Arthritis
Nutrition
Weight Loss
Tumor Necrosis Factor-alpha
Diet
Therapeutics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. / Di Minno, Matteo Nicola Dario; Peluso, Rosario; Iervolino, Salvatore; Russolillo, Anna; Lupoli, Roberta; Scarpa, Raffaele.

In: Annals of the Rheumatic Diseases, Vol. 73, No. 6, 2014, p. 1157-1162.

Research output: Contribution to journalArticle

Di Minno, Matteo Nicola Dario ; Peluso, Rosario ; Iervolino, Salvatore ; Russolillo, Anna ; Lupoli, Roberta ; Scarpa, Raffaele. / Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. In: Annals of the Rheumatic Diseases. 2014 ; Vol. 73, No. 6. pp. 1157-1162.
@article{9f7b54f078574b45980259b2ea5bee66,
title = "Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers",
abstract = "Objectives: To evaluate prospectively the effect of weight loss on the achievement of minimal disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting treatment with tumour necrosis factor α (TNFα) blockers. Methods: Among subjects with PsA starting treatment with TNFα blockers, 138 overweight/obese patients received a concomitant dietary intervention (69 a hypocaloric diet (HD) and 69 a free-managed diet (FD)). Changes in metabolic variables were measured and a complete clinical rheumatological evaluation was made in all patients at baseline and after a 6-month follow-up to define the achievement of MDA. Results: 126 subjects completed the study. MDA was more often achieved by HD than by FD subjects (HR=1.85, 95{\%} CI 1.019 to 3.345, p=0.043). A diet was successful (≥5{\%} weight loss) in 74 (58.7{\%}) patients. Regardless of the type of diet, after 6 months of treatment with TNFα blockers, ≥5{\%} of weight loss was a predictor of the achievement of MDA (OR=4.20, 95{\%} CI 1.82 to 9.66, p10{\%}), MDA was achieved by 23.1{\%}, 44.8{\%} and 59.5{\%}, respectively. A higher rate of MDA achievement was found in subjects with 5-10{\%} (OR=3.75, 95{\%} CI 1.36 to 10.36, p=0.011) and in those with >10{\%} (OR=6.67, 95{\%} CI 2.41 to 18.41, p",
author = "{Di Minno}, {Matteo Nicola Dario} and Rosario Peluso and Salvatore Iervolino and Anna Russolillo and Roberta Lupoli and Raffaele Scarpa",
year = "2014",
doi = "10.1136/annrheumdis-2012-202812",
language = "English",
volume = "73",
pages = "1157--1162",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

AU - Di Minno, Matteo Nicola Dario

AU - Peluso, Rosario

AU - Iervolino, Salvatore

AU - Russolillo, Anna

AU - Lupoli, Roberta

AU - Scarpa, Raffaele

PY - 2014

Y1 - 2014

N2 - Objectives: To evaluate prospectively the effect of weight loss on the achievement of minimal disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting treatment with tumour necrosis factor α (TNFα) blockers. Methods: Among subjects with PsA starting treatment with TNFα blockers, 138 overweight/obese patients received a concomitant dietary intervention (69 a hypocaloric diet (HD) and 69 a free-managed diet (FD)). Changes in metabolic variables were measured and a complete clinical rheumatological evaluation was made in all patients at baseline and after a 6-month follow-up to define the achievement of MDA. Results: 126 subjects completed the study. MDA was more often achieved by HD than by FD subjects (HR=1.85, 95% CI 1.019 to 3.345, p=0.043). A diet was successful (≥5% weight loss) in 74 (58.7%) patients. Regardless of the type of diet, after 6 months of treatment with TNFα blockers, ≥5% of weight loss was a predictor of the achievement of MDA (OR=4.20, 95% CI 1.82 to 9.66, p10%), MDA was achieved by 23.1%, 44.8% and 59.5%, respectively. A higher rate of MDA achievement was found in subjects with 5-10% (OR=3.75, 95% CI 1.36 to 10.36, p=0.011) and in those with >10% (OR=6.67, 95% CI 2.41 to 18.41, p

AB - Objectives: To evaluate prospectively the effect of weight loss on the achievement of minimal disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting treatment with tumour necrosis factor α (TNFα) blockers. Methods: Among subjects with PsA starting treatment with TNFα blockers, 138 overweight/obese patients received a concomitant dietary intervention (69 a hypocaloric diet (HD) and 69 a free-managed diet (FD)). Changes in metabolic variables were measured and a complete clinical rheumatological evaluation was made in all patients at baseline and after a 6-month follow-up to define the achievement of MDA. Results: 126 subjects completed the study. MDA was more often achieved by HD than by FD subjects (HR=1.85, 95% CI 1.019 to 3.345, p=0.043). A diet was successful (≥5% weight loss) in 74 (58.7%) patients. Regardless of the type of diet, after 6 months of treatment with TNFα blockers, ≥5% of weight loss was a predictor of the achievement of MDA (OR=4.20, 95% CI 1.82 to 9.66, p10%), MDA was achieved by 23.1%, 44.8% and 59.5%, respectively. A higher rate of MDA achievement was found in subjects with 5-10% (OR=3.75, 95% CI 1.36 to 10.36, p=0.011) and in those with >10% (OR=6.67, 95% CI 2.41 to 18.41, p

UR - http://www.scopus.com/inward/record.url?scp=84899951948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899951948&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2012-202812

DO - 10.1136/annrheumdis-2012-202812

M3 - Article

C2 - 23771989

AN - SCOPUS:84899951948

VL - 73

SP - 1157

EP - 1162

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -